- US inflation figures for March beat estimates but only marginally.
- Overhyped expectations may lead to a "buy the rumor, sell the fact" response.
- Another scare, about J&J's jabs, may also push the dollar lower.
Disappointment is the only option when expectations are so high – markets had been abuzz about surging inflation, making an "as expected" figure a trigger to sell off the dollar – exactly as previewed.
The Core Consumer Price Index came out at 1.6% yearly, exactly as the economic calendar showed. While headline CPI beat with 2.6% against 2.5%, that is hardly an earth-shattering result. However, the mild moves on the calendar have caused considerable price action – EUR/USD is some 30 pips higher, attacking the monthly highs. Other currencies are also gaining ground against the dollar.
Apart from the short-term reaction, it is essential to note that 1.6% annual underlying inflation was last seen in late 2020 – and it remains below the pre-pandemic levels above the 2% level. That 2% threshold is the Federal Reserve's target. Doomsday inflation will have to wait.
Officials at the world's most powerful central bank are probably sighing in relief, as they shrugged off any worries of rising prices as transitory. They can continue keeping interest rates near zero and pump $120 billion per month in bond-buying. For the dollar, it means additional pain in the medium term.
Returning to the nearer term, the greenback may be gearing up for another "buy the rumor, sell the fact" response. Authorities in the US have called to halt administering Johnson & Johnson's COVID-19 jabs, potentially slowing America's exit from the crisis. Immunization is also used in other countries.
The move came after six severe cases of blood clots were identified in the US, one of them tragically ending in death. However, nearly seven million people have received single-shot vaccines. That implies that after the dust settles, inoculations may return in some form.
The safe-haven dollar benefited from the scare. Will it be sold off once more information about these jabs is available?
Bank to the Future: Interest rates return to market center stage
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.
If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.
FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.
The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.
Recommended Content
Editors’ Picks
AUD/USD stays defensive below 0.6650 amid China worries
AUD/USD seems vulnerable below 0.6650 in Asian trading on Tuesday, undermined by mounting worries over China's economic slowdown. The Aussie shrugs off small rate cuts by the PBOC and a subdued US Dollar. Pre-US earnings results caution also weighs on the pair.
USD/JPY keeps losses below 157.00, as risk-off mood returns
USD/JPY remains under pressure below 157.00 early Tuesday. The Japanese Yen stays bid as risk-off flows return in the Asian session, sustaining the US Dollar weakness-driven downside in the pair. The pair looks to Japanese verbal intervention and mid-tier US data.
Gold price moves away from over one-week low, climbs back above $2,400 mark
Gold price extended its recent corrective slide from the record high touched last week and fell to a more than one-week trough on Monday. US President Joe Biden's withdrawal from the 2024 Presidential election increased the chances of Donald Trump becoming the next US President, raising hopes of a looser regulatory environment.
This week could be explosive for ETH: Ethereum ETFs to debut in the US on Tuesday
Ethereum is down nearly 1% on Monday as the SEC confirmed via its website on Tuesday that it has given the final approval for spot ETH ETFs. Considering the ETH ETF launch and the upcoming Bitcoin Conference, this week could prove crucial for Ethereum.
Earnings review
In recent years, the focus has been on the Magnificent 7, particularly Nvidia’s monster earnings reports, which have dominated the market. While Nvidia’s results are still extremely important for overall sentiment, there is a hope that sales growth and revenues can pick up across a broad range of global markets and sectors.